Alaska Wild Fish Oil Mega Omega-3
Product analysis
Alaska Wild Fish Oil Mega Omega-3 supplies EPA and DHA that may support healthy blood fats. The amounts of these two fats are clearly stated, but their chemical forms are unspecified, limiting comparison of absorption quality.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The chemical forms of EPA and DHA are not disclosed, so absorption quality is hard to compare. Other listed fats do not clarify that uncertainty.
Ingredient Transparency70
The separate EPA and DHA amounts make the active content easier to understand than total fish-oil weight alone. Their chemical forms are missing, which limits comparison between preparations.
Value For Money78
The serving offers good value for EPA and more moderate value for DHA. Value for the remaining fat content is uncertain.
Customer Satisfaction82
Customer feedback is strongly positive across a substantial number of ratings. The feedback supports satisfaction without proving cardiovascular or concentration benefits.
Product Focus76
The clearest purpose is supporting blood fats through EPA and DHA. Links to inflammation and longer-term brain nutrition are less certain and do not establish an immediate focus benefit.
- Format
Softgel - Container
- 90 Softgel(s)
- Per serving
- $0.41
- Customer rating
- 4.8 · 884 ratings
Goals
EPA and DHA can lower triglycerides, with direct evidence from much higher daily active amounts in selected populations. The separately disclosed active amounts are more informative than total fish-oil weight. The serving only partly matches those exposures, and triglyceride support does not establish prevention of cardiovascular events or rhythm stability.
How this product is rated for Cardiovascular Support
Ingredient fit83
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence83
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
EPA and DHA offer modest support for triglyceride and selected vascular measures. The explicitly declared amounts receive substantial recognition, with EPA leading the saved evidence contribution. This does not establish prevention of major cardiovascular events or reproduce prescription purified-EPA treatment findings. The DHA catalogue entries refer to the same active amount and do not represent additional DHA.
How this product is rated for Heart Health
Ingredient fit90
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence100
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
No linked studies yet.
EPA and DHA contribute to fatty-acid processes involved in inflammation, and supplied trials report changes in inflammatory markers with marine fatty acids. Results are inconsistent across studies and do not establish routine clinical benefit. The serving declares 965 mg EPA and 385 mg DHA separately; the saved result gives them unequal amount recognition, without treating total fish-oil weight as the active dose.
How this product is rated for Inflammation
Ingredient fit70
Goal fit
Dose adequacy
Pathways44
Depth
Breadth
Evidence70
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
DHA and EPA relate to longer-term brain nutrition rather than immediate focus. Positive DHA findings involved repeated use in adults with low intake and mainly memory or reaction-time outcomes. Long-term omega-3 results are mixed, so these findings do not establish an acute concentration benefit.
How this product is rated for Mental Focus
Ingredient fit77
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence56
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Total Fat | 2 Gram(s) | |
Polyunsaturated Fat | 1.5 Gram(s) | |
Cholesterol | 10 mg | |
Fish Oil | 1950 mg | |
Total EPA/DHA Omega-3 | 1350 mg | |
Eicosapentaenoic Acid | 965 mg | |
Docosahexaenoic Acid | 385 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability58
Molecular Form and Bioavailability
EPA Concentration Density
Oxidation Protection
Dose, Safety & Label Transparency92
Absolute EPA Dose per Serving
EPA-Centric Ratio
Purity and Contaminant Testing
Value100
Price per Gram of EPA
How this ingredient is rated
Active Ingredient Quality & Bioavailability44
Omega-3 Molecular Form
Purification & Filtration Method
Third-Party Purity & Potency Verification
Source & Sustainability
Dose, Safety & Label Transparency88
Total Active Omega-3 Dose (EPA + DHA)
Omega-3 Potency & Concentration
EPA & DHA Individual Disclosure
Oxidation Protection (Stabilizers)
Value100
Cost Per Gram of Active EPA + DHA
How this ingredient is rated
Active Ingredient Quality & Bioavailability59
DHA Chemical Form & Bioavailability
Oxidation Protection & Stability
Oil Concentration & Purity
Dose, Safety & Label Transparency73
DHA Absolute Dosage
Purity & Heavy Metal Verification
Ingredient Source Transparency
Value60
Price per Gram of DHA
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
- EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
- Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
- Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.